August 25, 2021
Articles & Publications Project Profiles Global Health

Single-Dose Drug Delivery Fill-Finish Facility ... within an Accelerated Timeline of Fewer Than 7 Months

Part 3: ApiJect committed to creating emergency temporary fill-finish capacity for up to 45M doses a month of a candidate COVID-19 vaccine on BFS lines by the end of 2020. All of these BFS-packaged doses could then be used, if necessary, in ApiJect Prefilled Injectors for scalable, single-dose delivery.

Might interest you

View All
Global Health
Affordable Prefilled Devices Greatly Expand Access
At Apiject, we believe a higher level of universal expanded access can be achieved by providing injectable medicine and vaccines in single-use, prefilled injectors that are simple, affordable, and can overcome many “Last Mile” challenges.
Global Health
ApiJect Systems Receives Grant to Develop Low-Cost Blow-Fill-Seal Prefilled Injection Device for Low- and Middle-Income Countries
Grant will fund the design and development of an affordable, multi-month contraceptive delivery device to enhance access in Low- and Middle-Income Countries (LMICs). Blow-Fill-Seal will be explored for the container closure and subcutaneous injection delivery system, advancing a concept initially developed by...
BFS Technology
The Advantages of BFS: Global Delivery Systems
A global delivery system for injectable drugs around the world has been hampered by many things. Production of glass vials, incredibly complicated, and fragile items.